NIH-funded research R01 grant

Imaging and Spectroscopy of Radiation Chemistry in FLASH Radiotherapy to Inform Clinical Translation

Funded at Rice University · NIH-11425869 · Data updated 2026-11-12

Researchers are studying why FLASH radiotherapy may spare healthy tissue while killing tumors, by measuring the very fast chemical processes that happen right after radiation.

More Radiotherapy research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRice University
NIH-funded
Lab location1 site (Houston, United States)
Project startJune 12, 2026
Project endMay 31, 2030
Funding year2026
Award (this year)$369,394
NIH project number1R01CA315651-01
Project IDNIH-11425869 on NIH RePORTER

Who could benefit from this research

Could help

Patients with cancers treatable by radiotherapy who may benefit from future FLASH RT approaches.

Less likely to help

Patients who will not be treated with FLASH RT or who are not candidates for radiotherapy may not benefit from this mechanistic work.

What this research studies

This project will use advanced optical and imaging techniques to observe how radiation creates reactive molecules in tissues and how these molecules behave within microseconds to milliseconds after exposure. By combining time-resolved spectroscopy, live-cell imaging, and in vivo measurements, the team aims to link chemical changes to DNA damage and tissue protection seen with FLASH. The goal is to generate mechanistic insights that could guide safer and more effective clinical use of FLASH RT. The work is designed to be conducted with clinically relevant irradiation conditions to ensure real-world relevance.

Why it matters

Potential benefit: If successful, the project could clarify how FLASH RT reduces normal tissue damage, helping clinicians optimize treatment plans for better patient outcomes.

How similar studies have gone: Previous research on FLASH RT has shown promising tissue-sparing effects; the exact mechanisms remain to be clarified, making this exploration both timely and novel.

Where this research is happening

  • Rice University
    Houston, United States
    Active

Researchers

  • Principal investigator: Gustavsson, Anna Karin Eva — Rice University
  • Study coordinator: Gustavsson, Anna Karin Eva

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.